News
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
1d
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotThe new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
19h
Zacks Investment Research on MSNMRNA Stock Jumps on CDC's Revised RSV Vaccine RecommendationsShares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since ...
A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...
A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results